The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total assets are โน7.902 Trillion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | โน7.878 T | -2.59% |
2023-12-31 | โน8.087 T | 50.09% |
2022-12-31 | โน5.388 T | 18.37% |
2021-12-31 | โน4.552 T | -1.11% |
2020-12-31 | โน4.603 T | 8.12% |
2019-12-31 | โน4.257 T | -8.32% |
2018-12-31 | โน4.643 T | -9.03% |
2017-12-31 | โน5.105 T | -3.22% |
2016-12-31 | โน5.275 T | 11.1% |
2015-12-31 | โน4.748 T | 8.56% |
2014-12-31 | โน4.373 T | 7.06% |
2013-12-31 | โน4.085 T | 37.41% |
2012-12-31 | โน2.972 T | 15% |
2011-12-31 | โน2.585 T | 32.67% |
2010-12-31 | โน1.948 T | 5.97% |
2009-12-31 | โน1.838 T | 4.98% |
2008-12-31 | โน1.751 T | 28.85% |
2007-12-31 | โน1.359 T | -9.16% |
2006-12-31 | โน1.496 T | 13.51% |
2005-12-31 | โน1.318 T | 4.18% |
2004-12-31 | โน1.265 T | 6.44% |
2003-12-31 | โน1.188 T | 1.38% |
2002-12-31 | โน1.172 T | 277.23% |
2001-12-31 | โน310.88 B |